NO902802D0 - Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus. - Google Patents

Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.

Info

Publication number
NO902802D0
NO902802D0 NO1990902802A NO902802A NO902802D0 NO 902802 D0 NO902802 D0 NO 902802D0 NO 1990902802 A NO1990902802 A NO 1990902802A NO 902802 A NO902802 A NO 902802A NO 902802 D0 NO902802 D0 NO 902802D0
Authority
NO
Norway
Prior art keywords
glycoproteins
human respiratory
gymoprotein
chemical
containing immunogenic
Prior art date
Application number
NO1990902802A
Other languages
English (en)
Other versions
NO902802L (no
NO300254B1 (no
Inventor
Michael Wathen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO902802L publication Critical patent/NO902802L/no
Publication of NO902802D0 publication Critical patent/NO902802D0/no
Publication of NO300254B1 publication Critical patent/NO300254B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO902802A 1987-12-23 1990-06-22 Fremgangsmåte for fremstilling av en vaksine mot humant respiratorisk syncytielt virus NO300254B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13738787A 1987-12-23 1987-12-23
PCT/US1988/003784 WO1989005823A1 (en) 1987-12-23 1988-10-31 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus

Publications (3)

Publication Number Publication Date
NO902802L NO902802L (no) 1990-06-22
NO902802D0 true NO902802D0 (no) 1990-06-22
NO300254B1 NO300254B1 (no) 1997-05-05

Family

ID=22477194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902802A NO300254B1 (no) 1987-12-23 1990-06-22 Fremgangsmåte for fremstilling av en vaksine mot humant respiratorisk syncytielt virus

Country Status (14)

Country Link
US (2) US5194595A (no)
EP (1) EP0396563B1 (no)
JP (1) JP2716503B2 (no)
KR (1) KR0137963B1 (no)
AT (1) ATE85622T1 (no)
AU (1) AU617739B2 (no)
CA (1) CA1320163C (no)
DE (1) DE3878468T2 (no)
DK (1) DK173175B1 (no)
FI (1) FI102382B1 (no)
HK (1) HK166295A (no)
MX (1) MX9203458A (no)
NO (1) NO300254B1 (no)
WO (1) WO1989005823A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914968D0 (en) * 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US5824307A (en) * 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
GB9200117D0 (en) 1992-01-06 1992-02-26 Connaught Lab Production of recombinant chimeric proteins for vaccine use
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
TW275632B (no) * 1992-04-21 1996-05-11 American Cyanamid Co
KR960700271A (ko) * 1993-01-08 1996-01-19 로렌스 티. 웰츠 인간 호흡계 합포체 바이러스 fg 당단백질의 정제 및 리폴딩 방법(process for the purification and refolding of human respiratory syncytial virus fg glycoprotein)
AU676340B2 (en) * 1993-05-25 1997-03-06 Wyeth Holdings Corporation Adjuvants for vaccines against respiratory syncytial virus
US7300918B2 (en) 1994-01-14 2007-11-27 Matthias Rath Method of producing vaccines from protein signal oligopeptides
ES2236703T3 (es) * 1994-01-14 2005-07-16 Matthias Dr Med Rath Uso de metodos para identificar oligopeptidos de señal hidrofilos.
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
US5789229A (en) * 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
FR2726472B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
DE4442114A1 (de) * 1994-11-25 1996-05-30 Buna Sow Leuna Olefinverb Gmbh Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6015664A (en) * 1995-11-03 2000-01-18 Mcw Research Foundation Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B
AU6908598A (en) * 1996-10-29 1998-05-22 Smithkline Beecham Biologicals (Sa) Purification of respiratory syncytial virus antigens
US6103466A (en) * 1997-07-14 2000-08-15 University Of Liege Double-muscling in mammals
PT2045322E (pt) * 1997-07-14 2015-10-16 Université de Liège Musculatura dupla em mamíferos
US20070067859A1 (en) * 1997-07-14 2007-03-22 Michel Georges Double-muscling in mammals
US6699478B1 (en) * 1997-09-19 2004-03-02 Wyeth Holdings Corporation Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
AU2001240020B9 (en) * 2000-03-01 2008-12-04 Medimmune, Llc High potency recombinant antibodies and method for producing them
ATE474854T1 (de) * 2000-01-27 2010-08-15 Medimmune Llc Rsv neutralisierende antikörper mit sehr hohen affinität
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
EA010404B1 (ru) * 2004-05-24 2008-08-29 Полимун Сайнтифик Иммунбиологише Форшунг Гмбх Сверхзагрузка липосом для доставки лекарственных веществ
CA2585891A1 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
EA021393B1 (ru) 2007-12-24 2015-06-30 Глаксосмитклайн Байолоджикалс С.А. Рекомбинантные антигены rsv
BRPI0915960A2 (pt) * 2008-07-18 2019-09-24 Id Biomedical Corp antígenos de polipeptídeos do vírus sincicial respiratório qimérico
SI2445526T1 (sl) 2009-06-24 2016-08-31 Glaxosmithkline Biologicals S.A. Rekombinantni RSV antigeni
ES2918381T3 (es) 2009-07-15 2022-07-15 Glaxosmithkline Biologicals Sa Composiciones de proteína F de VRS y métodos para producir las mismas
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CA2879915C (en) 2012-08-01 2022-07-05 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
AU605476B2 (en) * 1986-01-14 1991-01-17 University Of North Carolina, The Vaccines for human respiratory virus
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
SG106639A1 (en) * 2000-10-10 2004-10-29 Gen Electric Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating

Also Published As

Publication number Publication date
NO902802L (no) 1990-06-22
DK153290D0 (da) 1990-06-22
DE3878468D1 (de) 1993-03-25
MX9203458A (es) 1992-09-01
EP0396563A1 (en) 1990-11-14
CA1320163C (en) 1993-07-13
WO1989005823A1 (en) 1989-06-29
HK166295A (en) 1995-11-03
US5288630A (en) 1994-02-22
FI102382B (fi) 1998-11-30
KR0137963B1 (ko) 1998-04-30
FI102382B1 (fi) 1998-11-30
AU2785089A (en) 1989-07-19
DK173175B1 (da) 2000-03-06
JP2716503B2 (ja) 1998-02-18
ATE85622T1 (de) 1993-02-15
DK153290A (da) 1990-08-16
NO300254B1 (no) 1997-05-05
EP0396563B1 (en) 1993-02-10
JPH03501723A (ja) 1991-04-18
DE3878468T2 (de) 1993-06-09
US5194595A (en) 1993-03-16
FI903154A0 (fi) 1990-06-21
AU617739B2 (en) 1991-12-05
KR900700508A (ko) 1990-08-13

Similar Documents

Publication Publication Date Title
NO902802L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
DE60041280D1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
HK51597A (en) Vaccines for human respiratory virus
EP0294469A4 (en) VACCINES AND DIAGNOSTIC ANALYSIS FOR HAEMOPHILUS INFLUENZAE.
ATE234917T1 (de) Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung
ATE346931T1 (de) Clostridium perfringens impfstoff
DK311485D0 (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
MY101874A (en) Vaccine
DE3582422D1 (de) Biologische zubereitungen.
ATE15501T1 (de) Impfstoff fuer gefluegel gegen ansteckende bronchitis, zusammengesetzte impfstoffe gegen ansteckende bronchitis, verfahren zu deren herstellung und virusstamm der ansteckenden bronchitis.
AU3970099A (en) Avian polyomavirus vaccines in psittacine birds

Legal Events

Date Code Title Description
MK1K Patent expired